Gene: ABCC6
Official Full Name: ATP binding cassette subfamily C member 6provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38958 | ABCC6 Knockout cell line (HeLa) | Human | ABCC6 | 1:3~1:6 | Negative | Online Inquiry |
KO38959 | ABCC6 Knockout cell line (HCT 116) | Human | ABCC6 | 1:2~1:4 | Negative | Online Inquiry |
KO38960 | ABCC6 Knockout cell line (HEK293) | Human | ABCC6 | 1:3~1:6 | Negative | Online Inquiry |
KO38961 | ABCC6 Knockout cell line (A549) | Human | ABCC6 | 1:3~1:4 | Negative | Online Inquiry |
ABCC6 Gene Knockout Cell Lines are engineered cellular models developed to study the functional implications of the ABCC6 gene, which encodes an ATP-binding cassette (ABC) transporter involved in the transport of various substrates across cellular membranes. These knockout cell lines effectively facilitate the investigation of the physiological and pathological roles of ABCC6, particularly in relation to disorders such as pseudoxanthoma elasticum (PXE).
The primary function of these cell lines centers around the removal of the ABCC6 gene, which allows researchers to assess the resultant phenotypic changes within the cells, including altered substrate transport mechanisms and potential disruptions in mineralization processes. This knockout model enables comprehensive insights into the gene's role in metabolic pathways and cellular homeostasis, providing a clear advantage for elucidating the mechanistic pathways underlying ABCC6-associated diseases.
From a scientific standpoint, these cell lines are invaluable tools in both academic and clinical research settings. They can be employed to screen therapeutic compounds, explore gene therapy approaches, or develop biomarkers for monitoring disease progression. The precise knockout of the ABCC6 gene in a controlled laboratory environment allows for reproducible experimental results, enhancing the reliability of studies focused on this critical transporter.
One of the key selling points of our ABCC6 Gene Knockout Cell Lines is their specificity and validation, ensuring that researchers can depend on the fidelity of the findings generated from these models. Unlike general cell lines that may express varying levels of the target gene, our knockout lines provide a clean slate for meticulous experimentation, thus facilitating more straightforward interpretations of experimental outcomes.
Researchers and clinicians alike will find significant value in these knockout cell lines as they pave the way for breakthroughs in understanding gene function and potential gene-targeted therapies. Our company prides itself on its commitment to advancing biological research tools, backed by a team of experts dedicated to supporting the scientific community with high-quality, rigorously validated products that drive innovation in research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.